Patent · US Active

Synthetic mammalian retrotransposon gene

US9267932B2 · kind B2 · utility

6Cited by

2References

2Claims

0Family size

Assignee

THE JOHNS HOPKINS UNIVERSITY · US

Inventors

Jef D. Boeke · Baltimore, US
Jeffrey Han · Los Altos Hills, US

Key dates

Filing date	May 18, 2004
Grant date	Feb 23, 2016
Priority date	—
Expiry date	Mar 6, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2800/90
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to synthetic transposon and retrotransposon genes that exhibit higher levels of expression relative to natural transposon and retrotransposon genes. The invention further relates to transposons and retrotransposons comprising such synthetic genes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.